Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-04-19

Clinical Trial Update: Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease

View source ↗

Summary

Clinical trial update on identifying epigenetic biomarkers for the early detection of rheumatic diseases, including rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Arthritis Northwest PLLC | Conditions: Arthritis, Rheumatoid | Status: UNKNOWN